References
- Aaberg KM. Incidence and Prevalence of Childhood Epilepsy: a Nationwide Cohort Study.Pediatrics.2017;139.
- Aneja S, Jain P. Refractory epilepsy in children. Indian J. Pediatr. 2014;81(10):1063–1072.
- Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–1077. DOI:https://doi.org/10.1111/j.1528-1167.2009.02397.x.
- Wilder, RM The effects of ketonemia on the course of epilepsy . Mayo Clin Proc. 1921;2:307–308.
- Barzegar M, et al. Ketogenic diet: overview, types, and possible anti-seizure mechanisms. Nutr Neurosci. 2019;1–10. DOI:https://doi.org/10.1080/1028415X.2019.1627769.
- Cheng CM, Hicks K, Wang J, et al. Caloric restriction augments brain glutamic acid decarboxylase-65 and −67 expression. J. Neurosci. Res. 2004;77(2):270–276.
- Suzuki Y, Takahashi H, Fukuda M, et al. Beta-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes. Brain Res. 2009;1268:17–23.
- deCampo DM, Kossoff EH. Ketogenic dietary therapies for epilepsy and beyond. Curr Opin Clin Nutr Metab Care. 2019;22(4):264–268.
- Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet. Neurol. 2008;7(6):500–506. DOI:https://doi.org/10.1016/S1474-4422(08)70092-9.
- Sandu C, Burloiu CM, Barca DG, et al. Ketogenic Diet in Patients with GLUT1 Deficiency Syndrome. Maedica. 2019;14(2):93–97.
- Staretz-Chacham O, Pode-Shakked B, Kristal E, et al. The Effects of a Ketogenic Diet on Patients with Dihydrolipoamide Dehydrogenase Deficiency. Nutrients. 2021;13(10):3523. DOI:https://doi.org/10.3390/nu13103523.
- Inui T, Wada Y, Shibuya M, et al. Intravenous ketogenic diet therapy for neonatal-onset pyruvate dehydrogenase complex deficiency. Brain Dev. 2022;44(3):244–248. DOI:https://doi.org/10.1016/j.braindev.2021.11.005.
- Scholl-Bürgi S, Höller A, Pichler K, et al. Ketogenic diets in patients with inherited metabolic disorders. J. Inherit. Metab. Dis. 2015;38(4):765–773. DOI:https://doi.org/10.1007/s10545-015-9872-2.
- van der Louw E, van den Hurk D, Neal E, et al. Ketogenic diet guidelines for infants with refractory epilepsy. Eur. J. Paediatr. Neurol. EJPN Off. J. Eur. Paediatr. Neurol. Soc. 2016;20(6):798–809. DOI:https://doi.org/10.1016/j.ejpn.2016.07.009.
- Martin-mcgill KJ, Jackson CF, Bresnahan R, et al. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2018;11(CD001903).
- Iannone LF, Preda A, Blottière HM, et al. Microbiota-gut brain axis involvement in neuropsychiatric disorders. Expert Rev. Neurother. 2019;19(10):1037–1050. DOI:https://doi.org/10.1080/14737175.2019.1638763.
- Olson CA, Vuong HE, Yano JM, et al. The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet. Cell. 2018;173(1728–1741.e13):1728–1741.e13. DOI:https://doi.org/10.1016/j.cell.2018.04.027.
- Sourbron J, et al. Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis. Child’s Nerv. Syst. ChNS Off. J. Int. Soc. Pediatr. Neurosurg. 2020;36(6):1099–1109. DOI:https://doi.org/10.1007/s00381-020-04578-7.
- Riva A, et al. Emerging treatments for progressive myoclonus epilepsies. Expert Rev. Neurother. 2020;20(4):341–350. DOI:https://doi.org/10.1080/14737175.2020.1741350.
- van Egmond ME, et al. The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study. Orphanet J Rare Dis. 2017;12(45). DOI:https://doi.org/10.1186/s13023-017-0595-3.
- Liu YC. Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia. 2008;49(Suppl 8):33–36.
- Winesett SP, Bessone SK, Kossoff EHW. The ketogenic diet in pharmacoresistant childhood epilepsy. Expert Rev. Neurother. 2015;15(6):621–628.
- Kossoff EH, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;3(2):175–192. DOI:https://doi.org/10.1002/epi4.12225.
- Neal EG, Chaffe H, Schwartz RH, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009;50(5):1109–1117. DOI:https://doi.org/10.1111/j.1528-1167.2008.01870.x.
- Cervenka MC, Terao NN, Bosarge JL, et al. E-mail management of the modified Atkins Diet for adults with epilepsy is feasible and effective. Epilepsia. 2012;53(4):728–732. DOI:https://doi.org/10.1111/j.1528-1167.2012.03406.x.
- Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology. 2005;65(11):1810–1812.
- D’Andrea Meira I, et al. Ketogenic diet and epilepsy: what we know so far. Front Neurosci. 2019;13. DOI:https://doi.org/10.3389/fnins.2019.00005.
- Karimzadeh P, Sedighi M, Beheshti M, et al. Low Glycemic Index Treatment in pediatric refractory epilepsy: the first Middle East report. Seizure. 2014;23(7):570–572. DOI:https://doi.org/10.1016/j.seizure.2014.03.012.
- Kennedy RL, Khoo EYH. Health, Functional, and Therapeutic Implications of Obesity in Aging. In Handbook of Models for Human Aging. Amsterdam, the Netherlands: Elsevier Academic Pres; 2006. p. 829–839. DOI:https://doi.org/10.1016/B978-012369391-4/50070-9.
- Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. 1971;21:1097–1103.
- Martin-mcgill KJ, Jenkinson MD, Tudur Smith C, et al. The modified ketogenic diet for adults with refractory epilepsy: an evaluation of a set up service. Seizure. 2017;52:1–6.
- Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia. 2008;49(Suppl 8):37–41.
- Alqahtani F, Imran I, Pervaiz H, et al. Non-pharmacological Interventions for Intractable Epilepsy. Saudi Pharm. J. 2020;28(8):951–962. DOI:https://doi.org/10.1016/j.jsps.2020.06.016.
- Sharma S, Sankhyan N, Gulati S, et al. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia. 2013;54(3):481–486.
- Żółkiewicz J, Marzec A, Ruszczyński M, et al. Beyond Pre- and Probiotics. Nutrients. 2020;12(8):2189.
- Wegh CAM, Geerlings SY, Knol J, et al. Their Potential Applications in Early Life Nutrition and Beyond. Int. J. Mol. Sci. 2019;20(19):4673.
- Krishna V, Sammartino F, King NKK, et al. Neuromodulation for Epilepsy. Neurosurg. Clin. N. Am. 2016;27(1):123–131.
- Fisher RS, Velasco AL. Electrical brain stimulation for epilepsy. Nat Rev Neurol. 2014;10:261–270.
- Vassileva A, van Blooijs D, Leijten F, et al. Neocortical electrical stimulation for epilepsy: closed-loop versus open-loop. Epilepsy Res. 2018;141:95–101.
- Boon P, De Cock E, Mertens A, et al. Neurostimulation for drug-resistant epilepsy: a systematic review of clinical evidence for efficacy, safety, contraindications and predictors for response. Curr. Opin. Neurol. 2018;31(2):198–210.
- Heck CN, King‐Stephens D, Massey AD, et al. Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial. Epilepsia. 2014;55:432–441.
- Morrell MJ. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology. 2011;77(13):1295–1304.
- Starnes K, Miller K, Wong-Kisiel L, et al. A review of neurostimulation for epilepsy in pediatrics. Brain Sci. 2019;9(10):283.
- Lundstrom BN, Van Gompel J, Britton J, et al. Chronic Subthreshold Cortical Stimulation to Treat Focal Epilepsy. JAMA Neurol. 2016;73(11):1370–1372. DOI:https://doi.org/10.1001/jamaneurol.2016.2857.
- Ben-menachem E. Neurostimulation past, Present, and Beyond
- Sondhi V, Agarwala A, Pandey RM, et al. Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet Among Children With Drug-Resistant Epilepsy: a Randomized Clinical Trial. JAMA Pediatr. 2020;174:944–951.
- DeGiorgio CM, Krahl SE. Neurostimulation for drug-resistant epilepsy. Continuum. 2013;19:743–755. (Minneapolis, Minn). DOI:https://doi.org/10.1212/01.CON.0000431397.61970.2b.
- Bigelow MD, Kouzani AZ. Neural stimulation systems for the control of refractory epilepsy: a review. J. Neuroeng. Rehabil. 2019;16(1):1–17.
- Clancy MJ, Clarke MC, Connor DJ, et al. The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry. 2014;14(75). DOI:https://doi.org/10.1186/1471-244X-14-75
- He W, Jing X, Wang X, et al. Transcutaneous auricular vagus nerve stimulation as a complementary therapy for pediatric epilepsy: a pilot trial. Epilepsy Behav. 2013;28(3):343–346. DOI:https://doi.org/10.1016/j.yebeh.2013.02.001.
- Lulic D, Ahmadian A, Baaj AA, et al. Vagus nerve stimulation. Neurosurg Focus. 2009;27(E5):E5.
- Kulju T, Haapasalo J, Lehtimäki K, et al. Similarities between the responses to ANT-DBS and prior VNS in refractory epilepsy. Brain Behav. 2018;8(6):1–7.
- Kuba R, Brázdil M, Kalina M, et al. Vagus nerve stimulation: longitudinal follow-up of patients treated for 5 years. Seizure. 2009;18(4):269–274. DOI:https://doi.org/10.1016/j.seizure.2008.10.012.
- Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899–908. DOI:https://doi.org/10.1111/j.1528-1167.2010.02536.x.
- Elliott RE, Morsi A, Kalhorn SP, et al. Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav. 2011;20(1):57–63. DOI:https://doi.org/10.1016/j.yebeh.2010.10.017.
- Huf RL, Mamelak A, Kneedy-Cayem K. Vagus nerve stimulation therapy: 2-year prospective open-label study of 40 subjects with refractory epilepsy and low IQ who are living in long-term care facilities. Epilepsy Behav. 2005;6(3):417–423.
- Braun JM, et al. Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: the HOME study. Obesity (Silver Spring). 2016;24(1):231–237. DOI:https://doi.org/10.1002/oby.21258.
- Fregni F, Boggio PS, Santos MC, et al. Noninvasive cortical stimulation with transcranial direct current stimulation in Parkinson’s disease. Mov. Disord. 2006;21(10):1693–1702. DOI:https://doi.org/10.1002/mds.21012.
- Faria P, Hallett M, Miranda PC. A finite element analysis of the effect of electrode area and inter-electrode distance on the spatial distribution of the current density in tDCS. J. Neural Eng. 2011;8(6):066017.
- Auvichayapat N, Rotenberg A, Gersner R, et al. Transcranial direct current stimulation for treatment of refractory childhood focal epilepsy. Brain Stimul. 2013;6(4):696–700. DOI:https://doi.org/10.1016/j.brs.2013.01.009.
- Gil-López F, Boget T, Manzanares I, et al. External trigeminal nerve stimulation for drug resistant epilepsy: a randomized controlled trial. Brain Stimul. 2020;13(5):1245–1253. DOI:https://doi.org/10.1016/j.brs.2020.06.005.
- Chail A, Saini RK, Bhat PS, et al. Transcranial magnetic stimulation: a review of its evolution and current applications. Ind. Psychiatry J. 2018;27(2):172–180.
- Horvath JC, Perez JM, Forrow L, et al. Transcranial magnetic stimulation: a historical evaluation and future prognosis of therapeutically relevant ethical concerns. J Med Ethics. 2011;37(3):137–143.
- Rajapakse T, Kirton A. NON-INVASIVE BRAIN STIMULATION IN CHILDREN: APPLICATIONS AND FUTURE DIRECTIONS. Transl. Neurosci. 2013;4(2). DOI:https://doi.org/10.2478/s13380-013-0116-3
- Allen CH, Kluger BM, Buard I. Safety of Transcranial Magnetic Stimulation in Children: a Systematic Review of the Literature. Pediatr Neurol. 2017;68:3–17.
- Zewdie E, Ciechanski P, Kuo HC, et al. Safety and tolerability of transcranial magnetic and direct current stimulation in children: prospective single center evidence from 3.5 million stimulations. Brain Stimul. 2020;13(3):565–575. DOI:https://doi.org/10.1016/j.brs.2019.12.025.
- Masuda F, Nakajima S, Miyazaki T, et al. Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: a systematic review. Autism. 2019;23(7):1614–1629. DOI:https://doi.org/10.1177/1362361318822502.
- Majumder P, Balan S, Gupta V, et al. Efficacy of Repetitive Transcranial Magnetic Stimulation in the Treatment of Major Depression Among Children and Adolescents: a Systematic Review. Cureus. 2021;13(e14564 San Francisco, California,).
- VanHaerents S, Chang BS, Rotenberg A, et al. Noninvasive Brain Stimulation in Epilepsy. J Clin Neurophysio Off Publ Am Electroencephalogr Soc. 2020;37:118–130.
- Schramm S, Mehta A, Auguste KI, et al. Navigated transcranial magnetic stimulation mapping of the motor cortex for preoperative diagnostics in pediatric epilepsy. J Neurosurg Pediatr. 2021;1–8. DOI:https://doi.org/10.3171/2021.2.PEDS20901
- Zollman C, Vickers A. What is complementary medicine? Bmj. 1999;319(7211):693–696.
- Asadi-Pooya AA, Myers L, Valente K, et al. Pediatric-onset psychogenic nonepileptic seizures: a retrospective international multicenter study. Seizure. 2019;71:56–59.
- Sheth RD, Stafstrom CE, Hsu D. Nonpharmacological treatment options for epilepsy. Semin. Pediatr. Neurol. 2005;12(2):106–113.
- Farrukh MJ, Makmor-Bakry M, Hatah E, et al. Use of complementary and alternative medicine and adherence to antiepileptic drug therapy among epilepsy patients: a systematic review. Patient Prefer Adherence. 2018;12:2111–2121.
- Kneen R, Appleton RE. Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy. Arch. Dis. Child. 2006;91(11):936–941.
- Gaby AR. Natural approaches to epilepsy. Altern. Med. Rev. 2007;12(1):9–24.
- Mock DM, Stadler DD, Stratton SL, et al. Biotin status assessed longitudinally in pregnant women. J. Nutr. 1997;127(5):710–716.
- Verrotti A, Greco R, Morgese G, et al. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int. J. Clin. Lab. Res. 1999;29(1):36–40.
- Collins N, Maher J, Cole M, et al. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. The Quarterly journal of medicine. 1991;78(286):113–122.
- Grant ECG. Epilepsy and manganese. 2004;363(572):572. DOI:https://doi.org/10.1016/S0140-6736(04)15558-X.
- Torres OA, Miller VS, Buist NM, et al. Folinic acid-responsive neonatal seizures. J. Child Neurol. 1999;14(8):529–532.
- Sweis D. THE USES OF MELATONIN. In: editor. Arch. Dis. Child. - Educ. & Pract. 2005. Vol. 90 (London, UK). p. 74–77.
- Kneen R, Appleton R. Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy. Arch. Dis. Child. 2006;91(11):936–941.
- Schmitt B, Thun-Hohenstein L, Vontobel H, et al. Seizures induced by physical exercise: report of two cases. Neuropediatrics 25, 51–53 (1994).
- Malow BA. Sleep Deprivation and Epilepsy. Epilepsy Curr. 2004;4(5):193–195.
- Ramaratnam S, Baker GA, Goldstein LH. Psychological treatments for epilepsy. Cochrane Database Syst Rev. 2005. DOI:https://doi.org/10.1002/14651858.CD002029.pub2
- Kanner AM. Recognition of the various expressions of anxiety, psychosis, and aggression in epilepsy. Epilepsia. 2004;45(s2):22–27.
- Carbone L, Plegue M, Barnes A, et al. Improving the mental health of adolescents with epilepsy through a group cognitive behavioral therapy program. Epilepsy Behav. 2014;39:130–134.
- Shawahna R, Hattab S, Al-Shafei R, et al. Prevalence and factors associated with depressive and anxiety symptoms among Palestinian medical students. BMC Psychiatry. 2020;20(244). DOI:https://doi.org/10.1186/s12888-020-02658-1
- Panebianco M, Sridharan K, Ramaratnam S. Yoga for epilepsy. The Cochrane databaseof Systematic Reviews. 2017;10(CD001524). DOI:https://doi.org/10.1002/14651858.CD001524.pub3
- Nadkarni VS, Saxena VV. Nonpharmacological treatment of epilepsy. Annals of Indian Academy of Neurology. 2011;14(3):148–152.
- Wolf P, Koepp M. Reflex epilepsies. Handb Clin Neurol. 2012;107:257–276.
- Yucha CB, Montgomery D University of Nevada, Las Vegas. Association for Applied Psychophysiology and Biofeedback,. Evidence-based practice in biofeedback and neurofeedback. Nursing. 2008;6656 https://digitalscholarship.unlv.edu/nursing_fac_articles/1.
- Rockstroh B, Elbert T, Birbaumer N, et al. Cortical self-regulation in patients with epilepsies. Epilepsy Res. 1993;14(1):63–72. DOI:https://doi.org/10.1016/0920-1211(93)90075-I.
- Nagai Y. Biofeedback and epilepsy. Curr. Neurol. Neurosci. Rep. 2011;11(4):443–450.
- Sterman MB. Basic concepts and clinical findings in the treatment of seizure disorders with EEG operant conditioning. Clin. Electroencephalogr. 2000;31(1):45–55.
- Nigro SE. The Efficacy of Neurofeedback for Pediatric Epilepsy. Appl Psychophysiol Biofeedback. 2019;44(4):285–290.
- Micoulaud-Franchi JA, Lanteaume L, Pallanca O, et al. [Biofeedback and drug-resistant epilepsy: back to an earlier treatment?]. Rev. Neurol. 2014;170(3):187–196.
- Haut SR, Gursky JM, Privitera M. Behavioral interventions in epilepsy. Curr. Opin. Neurol. 2019;32(2):227–236.
- Brackney DE, Brooks JL. Complementary and Alternative Medicine: the Mozart Effect on Childhood Epilepsy-A Systematic Review. J Sch Nurs Off. Publ Natl. Assoc Sch Nurses. 2018;34:28–37.
- Coppola G, Operto FF, Caprio F, et al. Mozart’s music in children with drug-refractory epileptic encephalopathies: comparison of two protocols. Epilepsy Behav. 2018;78:100–103.
- Grylls E, Kinsky M, Baggott A, et al. Study of the Mozart effect in children with epileptic electroencephalograms. Seizure. 2018;59:77–81.
- Dawit S, Crepeau AZ. when drugs do not work: alternatives to antiseizure medications. Curr Neurol Neurosci Rep. 2020;20(37). DOI:https://doi.org/10.1007/s11910-020-01061-3
- Sesso G, Sicca F. Safe and sound: meta-analyzing the Mozart effect on epilepsy. Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol. 2020;131(7):1610–1620.
- Liao H, Jiang G, Wang X. Music therapy as a non-pharmacological treatment for epilepsy. Expert Rev. Neurother. 2015;15(9):993–1003.
- Betts T. Use of aromatherapy (with or without hypnosis) in the treatment of intractable epilepsy–a two-year follow-up study. Seizure. 2003;12(8):534–538.
- Davis, Patricia Aromatherapy an A-Z Penguin . . 2011 9781446446034 . https://www.penguin.com.au/books/aromatherapy-an-a-z-9781446446034 .
- Tisserand, Robert , Young, Rodney Elsevier 2nd 2013 9780443062414 . . https://www.elsevier.com/books/essential-oil-safety/tisserand/978-0-443-06241-4.
- Carroll B, Richardson JT, Thompson P. Olfactory information processing and temporal lobe epilepsy. Brain Cogn. 1993;22(2):230–243.
- Frye RE, et al. A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel. Front Public Health. 2013;1:1–26.
- Tyagi A, Herbal Remedies DN, Supplements D. Herbal Remedies, Dietary Supplements, and Seizures. Epilepsia. 2003;44(2):228–235.
- Xiao F, Yan B, Chen L, et al. Review of the use of botanicals for epilepsy in complementary medical systems - traditional Chinese medicine. Epilepsy Behav. 2015;52:281–289.
- Manchishi SM. Recent Advances in Antiepileptic Herbal Medicine. Curr. Neuropharmacol. 2018;16(1):79–83.
- Pittler MH, Ernst E. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J. Clin. Psychopharmacol. 2000;20(1):84–89.
- Amabeoku GJ, Leng MJ, Syce JA. Antimicrobial and anticonvulsant activities of Viscum capense. J. Ethnopharmacol. 1998;61(3):237–241.
- Pearl PL, Drillings IM, Conry JA. Herbs in Epilepsy: evidence for Efficacy, Toxicity, and Interactions. Seminars in Pediatric Neurology vol. 18 203–208 (2011).
- Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders - A randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry. 1997;30(1):1–5.
- Herbal Medicines SM. Epilepsy: the potential for benefit and adverse effects. Epilepsy Behav. 2001;2(6):524–532.
- Minami M, Kinoshita N, Kamoshida Y, et al. brinker is a target of dpp in drosophila that negatively regulates dpp- dependent genes. Nature. 1999;398(6724):242–246.
- Wang Q. Advances in treatment of epilepsy with traditional Chinese medicine. J Tradit Chinese Med. 1996;16:230–237.
- A TF Hung. Medical Bulletin. 2009
- Neel BA, Sargis RM. The paradox of progress: environmental disruption of metabolism and the diabetes epidemic. Diabetes. 2011;60(7):1838–1848.
- Wu JN. A short history of acupuncture. J AlternComplementary Med. 1996;2(1):19–21.
- Cheuk DKL, Yeung WF, Chung KF, et al. Acupuncture for insomnia. Cochrane Database Syst Rev. 2007. DOI:https://doi.org/10.1002/14651858.CD005472.pub2
- Maciocia. The foundations of chinese medicine - 1rd edition. https://www.elsevier.com/books/the-foundations-of-chinese-medicine/maciocia/978-0-7020-5216-3.
- Jansen G, Lundeberg T, Kjartansson J, et al. Acupuncture and sensory neuropeptides increase cutaneous blood flow in rats. Neurosci. Lett. 1989;97(3):305–309.
- Magnusson M, Johansson K, Johansson BB. Sensory stimulation promotes normalization of postural control after stroke. Stroke. 1994;25:1176–1180.
- Liu Q. Effects of acupuncture on hemorheology, blood lipid content and nail fold microcirculation in multiple infarct dementia patients. J. Tradit. Chinese Med. 2004;24:219–223.
- Middlekauff HR, Shah JB, Yu JL, et al. Acupuncture effects on autonomic responses to cold pressor and handgrip exercise in healthy humans. Clin. Auton. Res. 2004;14(2):113–118.
- Sun KO, Chan KC, Lo SL, et al. Acupuncture for frozen shoulder. Hong Kong Med. 2001;7:381–391.
- Liu W, Bai B, Song C, et al. The role of periaqueductal gray neurotensin in electroacupuncture analgesia. J Appl Physiol. 1997;13:253–256.
- Wu D. Mechanism of acupuncture in suppressing epileptic seizures. J Tradi Chinese Med. 1992;12:187–192.
- Shi ZY, Gong BT, Jia YW, et al. The efficacy of electro-acupuncture on 98 cases of epilepsy. J Tradit Chinese Med. 1987;7:21–22.
- Cheuk DKL, Wong V. Acupuncture for epilepsy. In: Cochrane database of systematic Reviews. Vol. (2014. vol;2014.
- Chen KY, Chen GP, Feng X. Observation of immediate effect of acupuncture on electroencephalograms in epileptic patients. J Tradit Chinese Med. 1983;3:121–124